Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;13(10):714-26.
doi: 10.1038/nrc3599.

Cancer drug resistance: an evolving paradigm

Caitriona Holohan  1 , Sandra Van Schaeybroeck, Daniel B Longley, Patrick G Johnston
Affiliations
Review

Cancer drug resistance: an evolving paradigm

Caitriona Holohan et al. Nat Rev Cancer. 2013 Oct.

Abstract

Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. BMC Cancer. 2010 Jul 15;10:370 - PubMed
    1. Lung Cancer. 2006 Nov;54(2):235-40 - PubMed
    1. Oncogene. 2011 Jan 6;30(1):1-20 - PubMed
    1. Oncogene. 2003 Oct 20;22(47):7512-23 - PubMed
    1. Blood. 2007 Jan 15;109(2):500-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources